FindTrial
Sign In

Prognostic prediction of head and neck squamous cell carcinomas with clinico-pathological parameters and Epidermal growth factor receptors expression status

Evaluation of clinico-pathological parameters and epidermal growth factor receptors expression status and design a mathematical model for prognosis of oral squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014222
Enrollment
50
Registered
2018-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx Health Condition 2: null- Medically fit for surgery

Interventions

None listed

Sponsors

MOHAMMAD AKHEEL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients with squamous cell carcinomas of oral cavity 2. Fungating/non-fungating tumor mass

Exclusion criteria

Exclusion criteria: 1.Any previous treatment(Surgery/chemo-radiation) 2. Sarcomas/melanomas/ basal cell carcinomas of head and neck. 3.Recurrence cases

Design outcomes

Primary

MeasureTime frame
To find whether there is association of EGFR and clinico-pathological factors with prognosis To find whether the model created helps us to find the prognosisTimepoint: 1 year—

Secondary

MeasureTime frame
To find prognosis of patientsTimepoint: 2 year—

Countries

India

Contacts

Public ContactDR MOHAMMAD AKHEEL

SAVEETHA UNIVERSITY

rinkugeorge@gmail.com9840069419

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026